Good Neighbor Pharmacy Franchise Cost, Revenue & Review 2026
Data from FDD filing + SBA 7(a) records
Analysis by FranchiseVerdict Research · Methodology
Good Neighbor Pharmacy is a franchise network of independently owned community pharmacies backed by distributor Cencora. Franchisees run local drugstores filling prescriptions, counseling patients, and selling retail health products while competing with chains and mail-order.
FranchiseVerdict summary · 2026
A Good Neighbor Pharmacy franchise requires a total initial investment of $279K – $575K. The 2026 FDD does not disclose unit-level revenue (no Item 19). SBA 7(a) loans show a 0.0% charge-off rate across 11 loans[1]. FranchiseVerdict grade: A (Strongest tier), an editorial assessment, not investment advice. Run a live ROI scan →
Data last verified · figures per the 2026 FDD issuance
Overview
- Investment
- $279K – $575K
- 57th pct Healthcare
- Avg gross sales
- N/A
- Combined outlet types
- Royalty
- N/A
- Units
- 2,361
- 80th pct Healthcare
- SBA charge-off
- 0.0%
- % of SBA 7(a) loans not repaid · median varies by category
Quick verdict · Healthcare · color = vs category peers
Green = favorable by >10% vs Healthcare avg · No shading = within ±10% · Red = unfavorable by >10% · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Bottom line
- COSTTotal investment $279K – $575K.
- RETURNSAudited consolidated financial statements are those of the franchisor's parent, Cencora, Inc. (formerly AmerisourceBergen Corporation), for fiscal year ended September 30, 2025; figures originally reported in thousands. Franchisor is AmerisourceBergen Drug Corporation.
- RISKVerdict A (Strongest tier), verdict score 75/100 (higher is better). SBA loan charge-off rate of 0.0% across 11 loans (well below the franchise average, based on all SBA 7(a) franchise lending, 2010–2025).
- FLAG264 units terminated last reporting year (11.2% of the system). Ask existing franchisees why.
Item 1 · who you're contracting with
The Franchisor
Corporate structure & franchisor financials
- Legal entity
- AmerisourceBergen Drug Corporation
- Parent company
- Cencora, Inc.
- Predecessor
- Bergen Brunswig Drug Company
- Prior franchisor entity
- CEO title
- President and Chief Executive Officer
- Robert P. Mauch
- Incorporated in
- DE
- HQ
- 1 West First Avenue, Conshohocken, PA 19428
- Auditor
- Ernst & Young LLP
- Audited financials
- Franchisor revenue
- $321.3B
- vs $294.0B prior year
Overview
About
- CEO
- Robert P. Mauch
- Headquarters
- PA
- Founded
- 1985
- FDD year
- 2026
- States available
- 51
Can you afford it, and what does the money buy?
Entry cost is about average for a healthcare franchise.
Source: FDD 2026 · Items 5–7
FDD Item 7 · 2026 filing
Initial investment breakdown
| Cost component | Low | High |
|---|---|---|
| Working capital (3–6 mo) | $120K | $150K |
| Equipment, build-out, other | $159K | $425K |
| Total initial investment | $279K | $575K |
Source: Good Neighbor Pharmacy 2026 FDD, Items 5 and 7[2]. “Equipment, build-out, other” is computed as total minus disclosed line items above.
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $279K – $575K
- Middle of category vs category
- Liquid capital req'd
- $120K – $150K
- Bottom third — review vs category
- Franchise fee
- N/A
- Top 40% of category vs category
- Royalty
- $599/month flat GNP Premier Fee (no percentage royalty)
- Ad fund
- No advertising fund or co-op required; franchisor not obl…
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Royalty (flat) | $599/month GNP Premier Fee; may increase upon 120 days notice |
| Inventory (initial) | $0 – $250K |
What do units actually make?
Source: FDD 2026 · Item 19
ROI & LBO modelsSingle-unit · 25-unit portfolio · editable
Good Neighbor Pharmacy did not disclose financial performance in FDD Item 19. The ROIC and return models require Item 19 revenue. Without it all inputs are estimates. You can still run the calculator with your own assumptions by entering an expected revenue figure.
Returns model · single-unit ROIC
What would one Good Neighbor Pharmacy unit return on the cash you put in?
Unlevered ROIC · per unit
Estimated return on your total franchise investment, before any debt financing.
21%
Below the 30–60% attractive-franchise band
These models are for research and scenario planning only. Not investment advice. Actual results depend on your specific location, management, and market conditions. Consult a franchise attorney and accountant before signing any franchise agreement.
Item 19 · Source: 2026 FDD
Financial Performance
Audited consolidated financial statements are those of the franchisor's parent, Cencora, Inc. (formerly AmerisourceBergen Corporation), for fiscal year ended September 30, 2025; figures originally reported in thousands. Franchisor is AmerisourceBergen Drug Corporation.
Combines different outlet types in one figure
- Item 19 type
- performance metrics
- Sample size
- 1,740
- vs category median 20 · large
- Reporting year
- 2026
- Fiscal year the figures cover
- Source filing
- FDD 2026
- The FDD edition these figures were read from
- Transparency
- 0 / 10
- vs category median 3 / 10 · below
Compared against 162 Healthcare brands
Operator outlook
What the numbers say
Data-driven interpretation of this brand's financial disclosures, fee structure, and system trajectory.
Disclosure
Item 19 reports performance metrics rather than annual gross sales, so unit revenue is not directly comparable.
Operator retention
System contracting at -4.1% CAGR over 3 years. Investigate whether closures are franchisor-driven consolidation or franchisee exits.
Source: FDD Item 19 financial performance representations and publicly filed FDD data. Past performance is not indicative of future results. Verify all figures with the franchisor and current franchisees before making any investment decision.
vs Healthcare averages
How Good Neighbor Pharmacy Compares
Is the system healthy?
Source: FDD 2026 · Item 20
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 2,361
- Opened
- 174
- Last reporting year
- Closed
- 264
- Terminated
- 264
- Franchisor ended the franchise (per Item 20)
- Non-renewed
- 0
- Term expired, not renewed (per Item 20)
- Turnover rate
- 12.0%
- Company-owned
- 0
- Corporate units in the system
- % franchised
- 100%
- vs corporate-owned
- Net growth (3-yr)
- -4.1%
- Net unit change over 3 years
- 3-yr CAGR
- -4.1%
- Compounded over last 3 years
3-year detail · Item 20
- Opened (3yr)
- 174
- Terminated (3yr)
- 264
- Non-renewed (3yr)
- 0
- Transfers (3yr)
- 45
- Reacquired (3yr)
- 0
- Franchisor bought back
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 24 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator. Not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee contact records (FDD Item 20). Shows states with at least one current operator on file. Full state registration data (Item 12) will appear on a future FDD refresh.
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
- Total loans
- 11
- Loan volume
- $23.1M
- Median loan
- $1.9M
- 50th percentile
- Charge-off rate
- 0.0%
- rates vary by category · see methodology
Historical SBA 7(a) lending data, not predictive of future performance. How SBA charge-off rates are calculated
- Repayment rate (PIF)
- 100.0%
- 5-yr charge-off
- N/A
- Loans approved 2021+
- Active lenders
- 5
- Defaults
- 0
- Typical loan rate
- 7.6%
- avg rate to borrowers
- Franchised industry avg
- 6.7%
- brand beats franchise avg ↓
- Jobs supported
- 262
- 1.1 per loan
- Lender concentration
- 45%
- top lender's share
Borrower mix: 0% went to startups / new businesses, 100% to established operators
Franchise vs independent — in pharmacies and drug stores, franchised businesses charge off at 6.7% vs 6.7% for independents
Top lenders financing Good Neighbor Pharmacy franchisees
Showing 3 of 5 lenders. The full breakdown — every lender, state distribution, interest rates & risk ratings — is in the SBA Lending Report below.
Explore lender portfolios on Bank Reports or regional data on State Reports.
Premium insight
SBA Lending Report
Deep-dive into Good Neighbor Pharmacy's SBA lending history: lender network, geographic footprint, interest rates, and more.
SBA Lending Report
- Principal loss rate and NAICS industry benchmark
- 5 lenders with concentration factor
- Per-state charge-off rates across 8 states
- Startup risk premium and job creation velocity
- 6-year lending trend
- SBA 504 real estate/equipment data
Instant access. No subscription.
With a 0.0% charge-off rate across 11 loans, banks have historically viewed this brand favorably for lending.
What could kill this investment?
SBA loans charge off at 0.0% — 100% below the 16.0% national norm, i.e. lower lender-observed risk.
Source: SBA 7(a) FOIA · FDD Items 3, 21
Risk analysis
FranchiseVerdict rating + FDD Items 3, 4, 8, 16, 21
Risk & Legal
High-risk investment in declining pharmacy franchise with severe regulatory/litigation exposure, going concern doubts, shrinking unit base, and opaque financial disclosure.
Litigation (Item 3)
Three disclosed matters: (1) Mullen/Omni/Sypula False Claims Act settlement ($625M); (2) National Prescription Opiate MDL litigation (various settlements including $4.3B Distributor Settlement Agreement); (3) DOJ civil complaint against Cencora/ABDC for Controlled Substances Act violations re suspicious order reporting.
Largest disclosed settlement: $625,000,000
Bankruptcy (Item 4)
None disclosed
Audited financials (Item 21)
Yes · Ernst & Young LLP
Franchisor revenue (Item 21)
Franchisor entity revenue (not unit-level)
ⓘ These are the parent company's consolidated financials (the parent guarantees the franchisor), not this brand's standalone results — the figure reflects the whole corporate group, not this brand alone.
Supplier relationship · Items 8 & 16
- Franchisor sells you products: Yes
- Must buy proprietary products: Yes
- Restricted to system-approved products: No
Score breakdown · what drove the 75 / 100 verdict
- 01MINORDeclining unit count (2,361 units, -4.6% YoY) indicates contracting franchise system with potential saturation or performance issues
- 02HIGHExtensive litigation history including False Claims Act settlements, opioid distribution MDL settlements, public nuisance verdict, and DOJ Controlled Substances Act violations creates significant legal and operational risk
- 03HIGHGoing Concern status is FALSE — indicates substantial doubt about franchisor's ability to continue operations, threatening franchisee support and brand viability
- 04MINORNo average revenue or net income disclosure (Item 19) prevents prospective franchisees from assessing realistic earning potential and ROI
- 05MINORUnprotected territory with $599 monthly royalty creates competitive vulnerability; franchisor can saturate your market without compensation
- 06MEDZero franchise fee indicates potential financial weakness of franchisor and limited resources for franchisee support and system development
Severity inferred from the FDD text · not a regulatory classification
What are you signing up for?
Source: FDD 2026 · Items 11, 12, 17
FDD Items 12, 15, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 5 years |
|---|---|
| Renewal term | 2 years |
| Territory type | none |
| Protected territory | No |
| Exclusive territoryℹ | No |
| Online sales rightsℹ | Granted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Optional |
| Right of first refusalℹ | No |
| Transfer requires consent | Yes |
| Termination notice | 60 days |
| Mandatory arbitration | No |
| Arbitration location | Conshohocken, PA (ABDC corporate headquarters) - mediation at ABDC option |
| Jury trial waiver | Yes |
| Governing law | PA |
| Litigation count | 3 |
View Item 3 litigation summary
Three disclosed matters: (1) Mullen/Omni/Sypula False Claims Act settlement ($625M); (2) National Prescription Opiate MDL litigation (various settlements including $4.3B Distributor Settlement Agreement); (3) DOJ civil complaint against Cencora/ABDC for Controlled Substances Act violations re suspicious order reporting.
Items 10, 11
Training & Operations
- Classroom training
- 0 hrs
- On-the-job training
- 0 hrs
- Training location
- None; no initial training currently offered
- Ongoing training
- Optional
- Site selection
- Franchisee
- Franchisor financing
- Not offered
- Item 10
Items 5 & 11
Franchisor Support
Item 20 · call current owners
Franchisee Contacts
141 owners to call
Name · phone · city · state. Extracted from FDD Item 20
FDD download
Good Neighbor Pharmacy · FDD (2026) PDF
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a Good Neighbor Pharmacy franchise?
The total investment to open a Good Neighbor Pharmacy franchise ranges from $279K – $575K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do Good Neighbor Pharmacy franchise owners earn?
Good Neighbor Pharmacy does not disclose average franchise owner earnings in their FDD Item 19. Not all franchisors are required to make financial performance representations. We recommend asking existing franchisees directly about their financial experience.
What is Item 19 in the Good Neighbor Pharmacy FDD?
The FDD section where a franchisor may disclose financial performance of its outlets. Disclosure is optional and formats vary; figures are typically gross sales, which is revenue before expenses, not profit. FranchiseVerdict extracts these figures directly from the Good Neighbor Pharmacy FDD and qualifies whose outlets they describe.
What is Good Neighbor Pharmacy's franchise failure rate?
Based on SBA 7(a) loan data, Good Neighbor Pharmacy has a charge-off rate of 0.0% across 11 loans, meaning 0.0% of franchise loans were charged off. Charge-off rates are one proxy for franchise risk, though they do not capture all closures. This data comes from FOIA-sourced SBA lending records.
How many Good Neighbor Pharmacy franchise locations are there?
As of their most recent FDD filing, Good Neighbor Pharmacy has 2,361 total units in the United States, including 2,204 franchised units and 0 company-owned units. 174 new units were opened in the latest reporting year.
Is Good Neighbor Pharmacy a good franchise to buy?
FranchiseVerdict rates Good Neighbor Pharmacy as a A-grade franchise with a verdict score of 75 out of 100 (higher is better), based on our analysis of investment costs, revenue data, SBA loan performance, and growth trends. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent Good Neighbor Pharmacy, you can request corrections or provide updated information.
Other Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.